The Food and Drugs Authority (FDA) of Ghana has reaffirmed its commitment to transparency and public health in the wake of allegations surrounding the extension of best-before dates for over 22,000 bags of 50kg rice. This rice, imported by Lamens Investments Africa Limited, was distributed to Senior High Schools (SHS), sparking widespread concern.
Addressing the issue during a news conference on November 26, FDA Chief Executive Officer, Dr. Delese Mimi Darko, emphasized that the agency adhered to strict regulatory standards and international best practices in its decision-making.
“The FDA is open to audits by qualified local and international bodies to validate all its actions,” she stated, adding that the authority operates in alignment with global protocols on food safety, including guidelines on use-by and best-before dates.
The controversy centers on claims that the FDA failed to conduct adequate due diligence before approving an extension of the rice's best-before date. Critics, including some public figures, have accused the agency of negligence. However, Dr. Darko defended the FDA's processes, noting that rigorous testing and compliance checks were undertaken.
She explained that such extensions are standard practice in food safety management globally and are only granted after thorough analysis confirms the product's safety and quality.
“All relevant certificates from India, the Plant Protection and Regulatory Services Directorate (PPRSD), and the Council for Scientific and Industrial Research-Food Research Institute (CSIR-FRI) confirmed the rice’s wholesomeness before it was released for distribution,” Dr. Darko assured.
The FDA’s position comes amid calls for accountability, with critics demanding stronger oversight of food safety practices. Dr. Darko reiterated the agency's readiness to engage in audits to address public concerns and validate its actions.
“We remain steadfast in our commitment to ensuring food safety and protecting public health,” she said.
In addition to addressing the immediate controversy, the FDA imposed a GH₵100,000 fine on Lamens Investments for regulatory violations, which it clarified was not related to the rice's safety but rather procedural breaches.
The issue has reignited discussions about food safety in Ghana, highlighting the need for robust regulatory frameworks and transparent processes. The FDA has faced growing pressure to restore public trust through proactive measures and continued adherence to best practices.
This article is based on reporting by MyJoyOnline.com.
blogpay
Total Comments: 0